Patients with type 2 diabetes lose weight, decrease insulin in meal replacement trial

June 11th, 2012
A pilot study shows that a protein-rich meal replacement made from soy, yogurt, and honey (Almased®) helps patients with type 2 diabetes lose weight, gain better control of their blood sugar, and decrease their daily insulin dose. Patients in the study also lowered their body mass index (BMI), waist and hip circumference, and fasting glucose levels, while improving their HDL-cholesterol and triglycerides. The results were reported at the American Diabetes Association's 72nd Scientific Sessions®.

"In light of the number of people with type 2 diabetes related to obesity, it's very important to investigate and explore any new tool that may have a positive effect on both weight and blood sugar," said Stephan Martin, MD, medical director of the West-German Diabetes and Health Centre in Düsseldorf, Germany, who conducted the study. "One of the most interesting findings to us was that Almased's positive effect on blood sugar was independent of its effect on weight loss."

Significant changes were seen at 12 weeks in the various study outcomes measured:

  • Average insulin dose decreased from 147 to 65 units per day (p<0.0001).
  • Weight decreased an average of 23 pounds (9%, p<0.0001).
  • Average HbA1c, which is an overall measure of how well blood sugar is controlled, decreased from 8.8% to 8.1% (p=0.048).
  • Fasting glucose, which is a measure of blood sugar after an eight-hour fast, decreased an average of 27.6 mg/dL (p=0.027).
  • BMI decreased an average of 2.6 kg/m2 (p<0.0001).
  • Average waist and hip circumferences decreased 2.8 inches (p=0.0003) and 1.3 inches (p=0.035), respectively.
  • Triglycerides decreased an average of 70.3 mg/dL (p=0.0001) while HDL-cholesterol increased 2.2 mg/dL (p=0.049).
While the formal study with Almased ended after 12 weeks, investigators followed up with patients after one and a half years. Four patients who continued to use Almased reported additional decreases in insulin doses, HbA1c, and weight. Two of these patients were able to stop insulin injections completely. The long-term use among some patients points to the ease of incorporating Almased into a daily dietary routine suitable for people with type 2 diabetes. A larger study of more than 300 patients is underway in Germany to confirm the findings of this pilot study. Both of these studies are sponsored by Almased-Wellness-GmbH.

"Some people will be surprised that patients could stop insulin completely; we need to change the thinking that once insulin is started there is no way to stop it," said Dr. Martin. "Motivated patients who are committed to long-term dietary changes and increased physical activity can make a real change in their weight and metabolic measures."

"The problem of obesity and type 2 diabetes is large and growing," said Silke Ullmann, MPH, RD, LDN, of Almased USA. "We are committed to studying Almased to see how it may help people lose weight and gain better control of blood sugar levels."

Provided by Alembic Health Communications

This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

'Mind the gap' between atomically thin materials

In subway stations around London, the warning to "Mind the Gap" helps commuters keep from stepping into empty space as they leave the train. When it comes to engineering single-layer atomic structures, minding ...

Seychelles poachers go nutty for erotic shaped seed

Under cover of darkness in the steamy jungles of the Seychelles thieves creep out to harvest the sizeable and valuable nuts of the famous coco de mer palm, and their activities are threatening its long-term ...

Can robots help stop the Ebola outbreak?

The US military has enlisted a new germ-killing weapon in the fight against Ebola—a four-wheeled robot that can disinfect a room in minutes with pulses of ultraviolet light.

Health care M&A leads global deal surge

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

New bird flu case in Germany

A worrying new strain of bird flu has been observed for the first time in a wild bird in northern Germany, the agriculture ministry said Saturday.

LiquidPiston unveils quiet X Mini engine prototype

LiquidPiston has a new X Mini engine which is a small 70 cubic centimeter gasoline powered "prototype. This is a quiet, four-stroke engine with near-zero vibration. The company said it can bring improvements ...